Ki-67, p53, ER Receptors, Ploidy and S Phase as Long-Term Prognostic Factors in T1 Node-Negative Breast Cancer
Authors:
- Mikael RailoMRMikael Railo
- Johan LundinJLJohan Lundin
- Caj HaglundCHCaj Haglund
- Karl von SmittenKSKarl von Smitten
- Stig NordlingSNStig Nordling
- 1 January 2007
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 28 (1) , 45-51
Abstract
The aim of the present study was to evaluate a series of biomarkers with regard to long-term prognostic value in patients with T1 (< or =2 cm) node-negative breast cancer. The prognostic value of Ki-67, p53, oestrogen receptor (ER) immunohistochemical labelling, flow-cytometric S phase fraction and ploidy was evaluated in 212 patients with pT1N0M0 breast cancer. The median follow-up time was 15.9 years (range 0.2-27.2 years). In an analysis of breast cancer-specific survival up to 5 years, high Ki-67 (> or =10%; p = 0.002), high p53 (> or =20%; p = 0.01), negative ER ( or =10%), high SPF (>3%) and high p53 (> or =20%) were compared to patients with other combinations (p = 0.03). According to the results of our series, it seems that several prognostic markers which are associated with short-term survival (< or =5 years) in pT1N0M0 breast cancer may not be significant predictors of long-term (>15 years) breast cancer-specific survival.Keywords
This publication has 22 references indexed in Scilit:
- Proliferation Marker Ki-67 in Early Breast CancerJournal of Clinical Oncology, 2005
- Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?Annals of Oncology, 2005
- A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast CancerNew England Journal of Medicine, 2004
- “Good Old” clinical markers have similar power in breast cancer prognosis as microarray gene expression profilersEuropean Journal of Cancer, 2004
- Ki‐67 expression in breast carcinomaCancer, 2003
- Ki-67, p53, Er-Receptors, Ploidy and S-Phase as Prognostic Factors in T1 Node Negative Breast CancerActa Oncologica, 1997
- Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancerBreast Cancer Research and Treatment, 1996
- The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins.Journal of Cell Biology, 1993
- p53 Mutations in Human CancersScience, 1991
- Indicators of Prognosis in Node-Negative Breast CancerNew England Journal of Medicine, 1990